HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

KDOAM-25

a KDM5 inhibitor; structure in first source

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 30675
  - Glycine: 5151
    - KDOAM-25: 3
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - Nicotinic Acids: 13
      - Niacinamide: 2223
        KDOAM-25: 3
- Heterocyclic Acids
  - Nicotinic Acids: 13
    - Niacinamide: 2223
      - KDOAM-25: 3

Experts

1.	Athanasou, Nick: 1 article (03/2017)
2.	Bountra, Chas: 1 article (03/2017)
3.	Brennan, Paul E: 1 article (03/2017)
4.	Burgess-Brown, Nicola A: 1 article (03/2017)
5.	Davies, Faith: 1 article (03/2017)
6.	England, Katherine S: 1 article (03/2017)
7.	Fedorov, Oleg: 1 article (03/2017)
8.	Hatch, Stephanie B: 1 article (03/2017)
9.	Hookway, Edward S: 1 article (03/2017)
10.	Johansson, Catrine: 1 article (03/2017)

Related Diseases

1.	Uveal melanoma 01/01/2023 - "Retracted: KDOAM-25 Overcomes Resistance to MEK Inhibitors by Targeting KDM5B in Uveal Melanoma." 01/01/2022 - "KDOAM-25 Overcomes Resistance to MEK Inhibitors by Targeting KDM5B in Uveal Melanoma."
2.	Multiple Myeloma 03/16/2017 - "Multiple myeloma MM1S cells treated with KDOAM-25 show increased global H3K4 methylation at transcriptional start sites and impaired proliferation."

Related Drugs and Biologics

1.	Mitogen-Activated Protein Kinase Kinases (MEKs)